Skip to content
Access, Saturation, Consolidation: Why Denmark Foreshadows the Future of Europe’s Medical Cannabis Markets
13th February 2026
Business
Read More
Rescheduling Optimism Fades, Cannabis Stocks Follow
12th February 2026
Markets & Stocks
Read More
France’s Long-Awaited Medical Cannabis Reimbursement Framework to Be Revealed Next Week
12th February 2026
Events
Read More
Can the Company That Built Australia’s Pastilles Market Do It Again in the UK?
11th February 2026
Business
Read More
News
Global Cannabis News & Analysis | Business of Cannabis
Latest News
Daily cannabis news and breaking stories from markets, policy, and medical sectors worldwide.
Industry Trends
Explore long-term trends shaping the global cannabis economy, from legalisation to innovation.
Opinion
Read expert opinions and analysis on policy, markets, and culture in the cannabis industry.
Editorial Picks
Hand-picked stories offering depth, insight, and perspective on global cannabis developments.
Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Public Markets
Explore the top publicly listed cannabis firms and market trends driving global valuation.
Investment & Finance
Insight into funding rounds, venture capital, and financial strategy shaping cannabis growth.
M&A Activity
The latest mergers, acquisitions, and strategic partnerships transforming the cannabis sector.
Policy & Regulation
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
UK & Europe
In-depth coverage of regulatory change and licensing frameworks across the UK & EU.
US & Canada
Analysis of federal and state cannabis reform shaping the North American market.
International Regulation
Country-by-country insight on legalisation models, trade rules, and compliance trends.
Legal Analysis
Expert commentary on cannabis law, IP, advertising, and risk management worldwide.
Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Patient Access
How patients obtain medical cannabis through licensed clinics and specialist prescribers.
Prescribers & Clinics
Resources and governance insight for clinicians and healthcare providers.
Pharmaceutical
Learn about the latest developments in the pharmaceutical cannabis industry with Business of Cannabis. Discover new drugs, research, and more.
CBD & Hemp
Data-driven coverage of CBD innovation, hemp policy, and wellness applications.
CBD Market
Stay informed about the latest trends and developments in the CBD industry with Business of Cannabis. Discover new products, industry insights, and more.
Hemp Industry
Explore the latest developments in the hemp industry with Business of Cannabis. Find out about new products, regulations, and more.
Products
What to look for in CBD oils, edibles, and supplements — testing, safety, and labelling.
Business
Intelligence for founders, operators, and investors building sustainable cannabis ventures.
Start-Ups
Entrepreneur stories, funding pathways, and lessons from emerging cannabis companies.
Retail & Brands
How leading cannabis retailers and brands design, market, and scale in regulated markets.
Cultivation
Supply Chain
Distribution, compliance, and efficiency trends powering cannabis supply networks.
Companies
Stay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Press releases
Stay informed about the latest developments and official statements in the cannabis industry with Business of Cannabis’ collection of press releases. Learn about new products, industry news and more from top companies.
Interviews
Exclusive conversations with CEOs and founders defining the cannabis economy.
Upcoming Events
Stay informed about upcoming cannabis events and conferences with Business of Cannabis. Learn about new products, industry insights, and more.
BofC New York
Cannabis Health Symposium
Cannabis Europa
Previous Events
Stay informed about upcoming cannabis events and conferences with Business of Cannabis. Learn about new products, industry insights, and more.
BofC Awards 2025
BofC x MJ Berlin
More
Recent Searches
Popular Searches
Glass Pharms
medical
Medical Cannabis
Kanabo Calls in Administrators
Article
Cannabis Health Symposium
antiflamx near me abbotsford bc
teaching feeling scene
for driving licence test
LEADER AM
Search
Recent Searches
Popular Searches
Glass Pharms
medical
Medical Cannabis
Kanabo Calls in Administrators
Article
Cannabis Health Symposium
antiflamx near me abbotsford bc
teaching feeling scene
for driving licence test
LEADER AM
Search
News
Latest News
Industry Trends
Opinion
Editorial Picks
Markets & Stocks
Public Markets
Investment & Finance
M&A Activity
Policy & Regulation
UK & Europe
US & Canada
International Regulation
Legal Analysis
Medical
Medical Cannabis
Patient Access
Prescribers & Clinics
Pharmaceutical
CBD & Hemp
CBD Market
Hemp Industry
Products
Business
Start-Ups
Retail & Brands
Cultivation
Supply Chain
Companies
Press releases
Interviews
Upcoming Events
BofC New York
Cannabis Health Symposium
Cannabis Europa
Previous Events
BofC Awards 2025
BofC x MJ Berlin
Home
/
News
/
Opinion
/
Page 4
Opinion archive
Filter By Year:
2025
2024
2023
2022
2021
2020
2019
2018
2017
Sort News:
Oldest
Newest
Filter By Category:
Editorial Picks
Industry Trends
Latest News
Opinion
Adult-Use
Opinion: former Juicy Fields CEO shares his thoughts on the case
By
Stephanie Price
August 02, 2022
Opinion
Despite US federal court ruling Delta-8-THC remains in legal limbo – what’s next?
By
Joe Roberts
July 15, 2022
Medical
Having A Fair, Reciprocal Relationship With Patients ‘Isn’t Just The Right Thing To Do, It Simply Makes Business Sense’
By
Ben Stevens
July 14, 2022
CBD Market
EFSA’s Request For Human CBD Toxicology Data Is ‘Unusual’ For a Food Authority
By
Peter
June 27, 2022
Adult-Use
European Cannabis Industry ‘Potentially An Even Bigger Opportunity’ Than The US, And Investors Should ‘Wake Up To The Opportunities In Their Own Backyard’
By
Ben Stevens
May 25, 2022
Adult-Use
Akanda’s Tej Virk Has A Message For The Portuguese Government – “Legalise It Before Germany”
By
Laura Ramos
May 09, 2022
Medical
Brains Bioceutical: building a cannabis dream team
By
admin
April 27, 2022
Opinion
US Hemp Industry Has Sights On Europe As It Looks To Overcome Technical Trade Hurdles
By
BusinessCann
April 19, 2022
Opinion
Is digital marketing the future for cannabis marketing?
By
Jack Pierce
March 29, 2022
Adult-Use
Alfredo Pascual: the changing landscape of cannabis
By
Stephanie Price
February 25, 2022
Opinion
Securing Novel Foods Validation is a Highly Rigorous Process That is Both Costly and Time-Consuming for Companies
By
BusinessCann
February 23, 2022
CBD Market
Forcing CBD And Hemp Consumption Down The Isolate Route Will Cause Significant Harm To The Industry
By
BusinessCann
January 26, 2022
Adult-Use
Expect An Influx Of Capital Into Established European Cannabis Businesses Able To Execute On Their Plans
By
BusinessCann
January 04, 2022
Adult-Use
2022 Will See The Race To The Bottom Replaced By A Healthy Focus On Profitable Business Models
By
BusinessCann
December 30, 2021
Adult-Use
Germany Needs Workable Adult-Use Legislation Capable Of Drying-Up The Illicit Market.
By
BusinessCann
December 22, 2021
CBD Market
CBD Consumers Want Trusted Brands And High-Quality Products Backed By Regulators and Retailers
By
BusinessCann
December 21, 2021
Adult-Use
‘The European Cannabis Industry Has Passed The Point Of No Return’
By
BusinessCann
December 20, 2021
CBD Market
Europe’s Decision to Raise Permitted THC Levels in Hemp Crops Is ‘A Victory For Science’
By
BusinessCann
December 15, 2021
✕
Loading…